Side Effects of Rituxan for MS Treatment May Carry Increased Infection Risks: Study
Some newer MS drugs increase the risk of infection, according to the findings of a new study.
Some newer MS drugs increase the risk of infection, according to the findings of a new study.
A new study looking at the uses and side effects of Actemra, Enbrel and Rituxan suggests that observational studies may be a better predictor of drug effectiveness and safety than…
A case study links the side effects of Rituxan use during pregnancy to episodes of sepsis in a newborn whose immune system may have been compromised when the leukemia drug…
Johns Hopkins researchers warn that the drug industry is exploiting a law meant to help unprofitable drugs meant to treat small populations with rare diseases to get big, blockbuster medications…
The FDA has linked the leukemia drugs Rituxan and Arzerra to reactivation of hepatitis B virus and deaths due to liver failure.
Genentech has agreed to pay $20 million to settle a whistleblower lawsuit filed over claims that the drug maker aggressively marketed Rituxan for off-label uses and trained sales reps how…
New cases of a rare brain infection, progressive multifocal leukoencephalopathy (PML), have been liked to the lymphoma and arthritis drug Rituxan and the multiple sclerosis (MS) drug Tysabri. The cases…
A new case of a rare, often lethal, brain infection has been linked to the multiple sclerosis drug Tysabri, making it the ninth case of progressive multifocal leukoencephalopathy (PML) infection…
Biogen Idec Inc. indicates that another multiple sclerosis patient may have developed a rare and potentially life-threatening brain infection known as progresive multifocal leukoencephalopathy from side effects of Tysabri.
Following reports that link side effects of Rituxan to fatal brain infections, the FDA is reviewing whether users of the cancer-fighting drug should use the medication for shorter periods of…